GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SC Ropharma SA (BSE:RPH) » Definitions » PEG Ratio

SC Ropharma (BSE:RPH) PEG Ratio : 5.56 (As of May. 08, 2024)


View and export this data going back to 1997. Start your Free Trial

What is SC Ropharma PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, SC Ropharma's PE Ratio without NRI is 63.33. SC Ropharma's 5-Year EBITDA growth rate is 11.40%. Therefore, SC Ropharma's PEG Ratio for today is 5.56.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for SC Ropharma's PEG Ratio or its related term are showing as below:

BSE:RPH' s PEG Ratio Range Over the Past 10 Years
Min: 0.75   Med: 1.29   Max: 5.56
Current: 5.56


During the past 13 years, SC Ropharma's highest PEG Ratio was 5.56. The lowest was 0.75. And the median was 1.29.


BSE:RPH's PEG Ratio is ranked worse than
85.27% of 224 companies
in the Healthcare Providers & Services industry
Industry Median: 1.57 vs BSE:RPH: 5.56

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


SC Ropharma PEG Ratio Historical Data

The historical data trend for SC Ropharma's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SC Ropharma PEG Ratio Chart

SC Ropharma Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.35 1.78 1.99 1.29 0.87

SC Ropharma Semi-Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Jun23
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.29 - 0.87 - -

Competitive Comparison of SC Ropharma's PEG Ratio

For the Pharmaceutical Retailers subindustry, SC Ropharma's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SC Ropharma's PEG Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SC Ropharma's PEG Ratio distribution charts can be found below:

* The bar in red indicates where SC Ropharma's PEG Ratio falls into.



SC Ropharma PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

SC Ropharma's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=63.333333333333/11.40
=5.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


SC Ropharma  (BSE:RPH) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


SC Ropharma PEG Ratio Related Terms

Thank you for viewing the detailed overview of SC Ropharma's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SC Ropharma (BSE:RPH) Business Description

Traded in Other Exchanges
N/A
Address
Str. Iuliu Maniu Nr. 55, ETAJ 1, Brasow, ROU, 500091
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.

SC Ropharma (BSE:RPH) Headlines

No Headlines